CW September 2005
Volume 14Issue Number 9 September 2005 ISSN 10593802 Combination Chemotherapy and Immunotherapy for Non-Hodgkin?s LymphomaA new study result published in the August 20, 2005 issue of The Journal of Clinical Oncology indicates that treatment with radiolabeled monoclonal antibody tositumomab (Bexxar®) following fludarabine chemotherapy produces excellent response in previously untreated low-grade/follicular non-Hodgkin?s lymphoma (NHL) patients.
Go to Previous Page Go to Next Page J. P. Leonard, The Journal of Clinical Oncology, August 20, 2005. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW September 2005Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
